Arterex Strengthens Medical Device Manufacturing Capabilities with Acquisition of Micromold
Acquisition Expands Arterex’s Precision Molding Capabilities
In a bold move to bolster its medical device manufacturing prowess, Arterex, a prominent developer and contract manufacturer, has strategically acquired Micromold, a seasoned provider of custom precision micromoulded parts for the medical industry. This acquisition marks a significant expansion of Arterex’s expertise and capabilities in crafting high-quality medical components.
Micromold’s Expertise Complements Arterex’s Portfolio
Established in 1984, Micromold has amassed a wealth of experience in plastics injection moulding, catering to diverse industries such as medical, diagnostics, optical, dental, and laboratory. Their comprehensive range of services includes mould design, product development and fulfilment, making them a valuable addition to Arterex’s offerings. The acquisition of Micromold aligns seamlessly with Arterex’s commitment to delivering innovative and reliable medical solutions.
Integration into Formula Plastics Division
Micromold’s operations, previously based in Riverside, California, will be seamlessly integrated into Arterex’s Formula Plastics division, situated in Tecate, Mexico. This integration will leverage Micromold’s state-of-the-art equipment, including 20 BOY machines ranging from 10 to 33 tons in vertical and horizontal configurations, within Arterex’s 3,000 sq ft Class 8 certified cleanroom. This move not only expands Arterex’s manufacturing capacity but also ensures uninterrupted service to Micromold’s existing customer base.
Quality Assurance and Regulatory Compliance
Micromold’s dedication to quality and compliance complements Arterex’s commitment to excellence. The company operates under a rigorous ISO13485:2016 Quality System and is registered with the FDA, ensuring adherence to stringent regulatory standards. This unwavering focus on quality and compliance will continue to be a cornerstone of the combined entity’s operations.
Leadership Perspective
Bill Gerard, President of Arterex, North America, expressed his enthusiasm about the acquisition, highlighting the synergies between the two companies. He stated, “Micromold brings with it over 40 years of expertise from mould design to end customer fulfilment service that allows us to expand our services and capabilities to our growing customer base. The company is an ideal addition to our offering of high-quality precision injection moulded medical components, assemblies, product design and development services.”
Enhancing Customer Value through Collaboration
The acquisition of Micromold represents a strategic move for Arterex, enabling the company to offer a more comprehensive suite of services to its customers. By leveraging Micromold’s expertise in precision moulding and integrating it with Arterex’s existing capabilities, the combined entity will be better equipped to meet the evolving needs of the medical industry. This acquisition is a testament to Arterex’s commitment to delivering innovative and high-quality solutions to its valued customers.
With this strategic acquisition, Arterex positions itself as a leading provider of medical device manufacturing solutions, setting a new standard for quality, innovation, and customer satisfaction. The company is poised to make significant contributions to the advancement of healthcare technology, improving patient outcomes and transforming the industry.